Duplex-Doppler evaluation of the effects of propranolol and isosorbide- 5-mononitrate on portal flow and splanchnic arterial circulation in cirrhosis

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 5, 1998, Pages 475-481

  Piscaglia, F ^a   Gaiani, S ^a   Siringo, S ^a   Gramantieri, L ^a   Serra, C ^a   Bolondi, L ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ISOSORBIDE 5 NITRATE; NITRATE; PROPRANOLOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DRUG EFFECT; ESOPHAGUS VARICES; FEMALE; HEART RATE VARIABILITY; HUMAN; KIDNEY CIRCULATION; LIVER CIRRHOSIS; MALE; PATIENT CODING; PATIENT SELECTION; PORTAL VEIN BLOOD FLOW; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; SPLANCHNIC BLOOD FLOW;

EID: 0031833251     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00333.x     Document Type: Article

References (26)

1. de Franchis R, Pascal JP, Ancomi E, et al. Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop. J Hepatol 1992; 15: 256-61.
2. Merkel C, Marin R, Enzo E, et al. Randomised trial of nadolol alone or with isosorbide mononitrate from primary prophylaxis of variceal bleeding in cirrhosis. Lancet 1996; 348: 1677-81.
3. Gaiani S, Bolondi L, Fenyves D, et al. Effect of propranolol on portosystemic collateral circulation in patients with cirrhosis. Hepatology 1991; 14: 824-9.
4. Barbara L. The value of Doppler US in the study of hepatic hemodynamics. Consensus conference. Planning Committee: L. Barbara, L. Bolondi, P. N. Burns, S. Gaiani. J Hepatol 1990; 10: 353-5.
5. Sabbà C, Merkel C, Zoli M, et al. Interobserver and interequipment variability of echo Doppler examination of the portal vein: effect of a cooperative training program. Hepatology 1995; 21: 428-55.
6. Zoli M, Merkel C, Sabbà C, et al. Interobserver and interequipment variability of echo-Doppler sonographic evaluation of the superior mesenteric artery. J Ultrasound Med 1996; 15: 99-106.
7. Sacerdoti D, Zoli M, Gaiani S, et al. Interobserver and interequipment variability of hepatic, splenic and renal arterial Doppler resistance indices in normal subjects and cirrhotic patients. J Hepatol 1997; 27: 986-92.
8. Bolognesi M, Sacerdoti D, Merkel C, et al. Effects of chronic therapy with nadolol on portal hemodynamics and on splanchnic impedance indices using Doppler sonography: comparison between acute and chronic effects. J Hepatol 1997; 26: 305-11.
9. Tincani E, Cioni G, Cristani A, et al. Duplex-Doppler ultrasonographic comparison of the effects of propranolol and isosorbide-5-mononitrate on portal hemodynamics. J Ultrasound Med 1993; 12: 525-9.
10. Zoli M, Marchesini G, Brunori A, Cordiani MR, Pisi E. Portal venous How in response to acute beta-blocker and vasodilatatory treatment in patients with liver cirrhosis. Hepatology 1986; 6: 1248-51.
11. Merkel C, Sacerdoti D, Bolognesi M, et al. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone. Hepatology 1997; 26: 34-9.
12. Garcia-Tsao G, Grace ND, Groszmann RJ, et al. Short-term effects of propranolol on portal venous pressure. Hepatology 1986; 6: 101-6.
13. Navasa M, Chesta J, Bosch J, Rodes J. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Gastroenterology 1989; 96: 1110-18.
14. Groszmann RJ, Bosch J, Grace ND, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990; 99: 1401-7.
15. Vorobioff J, Picabea E, Villavicendo R, et al. Acute and chronic effects of propranolol in unselected cirrhotic patients. Hepatology 1987; 7: 648-55.
16. Japanese Research Society for Portal Hypertension. The general rules for recording endoscopic findings on esophageal varices. Jpn J Surg 1980; 10: 84-7.
17. Moriyasu F, Ban N, Nishida O, et al. Clinical application of an ultrasonic duplex system in the quantitative measurement of portal blood flow. J Clin Ultrasound 1986; 14: 579-88.
18. Burns PN. Interpreting and analyzing the Doppler examination. In: Taylor KJW, Burns PN, Wells PNT, eds. Clinical Applications of Doppler Ultrasound. New York: Raven Press, 1995: Chap. 4, 90.
19. Aramaki T, Sekiyama T, Katsuta Y, et al. Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitravasodilating properties, in patients with portal hypertension due to cirrhosis. J Hepatol 1992; 15: 48-53.
20. Merkel C, Sacerdoti D, Bolognesi M, et al. Failure of acute challenge with nadolol to predict long-term portal hemodynamic effect in patients with cirrhosis: an assessment using invasive and non-invasive techniques. Ital J Gastroenterol 1994; 26: 208-9 A.
21. Albillos A, Paramo MP, Cacho G, et al. Accuracy of the non-invasive measurement of portal (PBF) and forearm blood flow (FBF) in the assessment of the portal pressure response to propranolol. Hepatology 1996: 24(Suppl.): 206 A.
22. Viudez P, Castano G, Carlevaro O, et al. Comparative study between duplex-Doppler US and invasive hemodynamic measurements: response to i.v. propranolol in cirrhotic patients with portal hypertension. Hepatology 1996: 24(Suppl.): 205 A.
23. Garcia-Pagan JC, Feu F, Bosch J, Rodes J. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled trial. Ann Intern Med 1991; 114: 869-73.
24. Merkel C, Gatta A, Donada C, et al. Long-term effect of nadolol or nadolol plus isosorbide-5-mononitrate on renal function and ascites formation in patients with cirrhosis. Hepatology 1995; 22: 808-13.
25. Garcia-Pagan JC, Navasa M, Bosch J, et al. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis. Hepatology 1990; 11: 230-8.
26. Bolognesi M, Sacerdoti D, Merkel C, Gatta A. Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients. J Ultrasound Med 1994; 13: 946-52.